Trialect

+ More Filters

Reset Filters

Specialty

Funding Organization

Funding Type

Eligible Country

Deadline

From

Other (Select all that apply)

Show Expired Programs

Show Verified Programs

Verified

ASH Graduate Hematology Award

American Society of Hematology

The ASH Graduate Hematology Award encourages graduate students in the United States and Canada to pursue a career in academic hematology. The award provides funding for students conducting research on hematology-focused projects and is open to doctoral students in their first, second, or third year of graduate school at the time of application.

Program Benefits

The award provides an annual $40,000 stipend for a two-year period that can be used for tuition/salary/stipend (no more than 70%), research, training-related expenses (including health insurance), and travel to the ASH Annual Meeting and Exposition.

Program participants receive complimentary ASH membership throughout graduate school.

Supported Research

Applicants must submit proposals to conduct research in hematology. Proposals that fall within any of the categories discussed below are encouraged:

Basic Research
Translational Research
Patient-Oriented Clinical Research
Outcomes-Based Research

For additional details on eligible research categories, please consult the Research Definitions page.

Application Process

The AGHA application, as well as all supporting documents outlined below, must be submitted through the ASH online awards system.

All applications must include the following:

Applicant NIH Biographical Sketch
Research Mentor NIH Biographical Sketch
Applicant Career Development Plan
Personal Statement
Project Proposal
Mentor Letter of Support
Institutional Commitment Letter from Department Chair

For more information about the required materials, please see the Required Documents PDF.

Evaluation, Selection, and Notification

Applications submitted by the deadline will be reviewed by the MRI Study Section (ASH Committee on Promoting Diversity). Applicants will be evaluated on the following criteria:

A focus on hematology research
The applicant’s qualifications and experiences; factors to be considered include, but are not limited to, the potential for future independent investigation and commitment to a career in hematology research
Quality of the mentor and the plan for mentor-applicant interaction and career development.
The significance, feasibility, and originality of the proposed hypothesis, research, and methodology.
Availability of institutional resources to support the proposed project.
While not an excluding factor, consideration will be given to insuring a balance between PhD and MD/PhD programs

There is no limit to the number of applications that an institution and its affiliates may submit. However, no more than one award will be granted for any given institution. For this purpose, ASH’s definition of “medical school” encompasses all affiliate institutions (e.g., University of Washington would include the Fred Hutchinson Cancer Research Center, Seattle Children's Hospital, etc.).

Terms and Conditions

All awards will be activated on July 1 and will conclude on June 30 of the final year. Payment will be made to the appropriate financial officer for the institution as indicated on the proposed budget form.

As a condition of acceptance of the ASH Graduate Hematology Award, it is required that:

All funds must be used for the research project specified in the application submitted to ASH in strict compliance with the budget included with the application or any subsequent budget approved by the Society.
- Indirect costs (e.g., facilities and administration costs) are not allowed.
AGHA recipients cite support from the American Society of Hematology in any publication describing research conducted during the period of the award.
The award recipient must dedicate at least 65-75 percent (approximately 2704 – 3120 hours of protected time devoted to research over the two-year time period) of his/her full-time professional efforts to research during the funded period.
Award recipients complete program surveys during and after the award period, which ASH will use to measure the effectiveness of the program.

Reallocation

Students may request a reallocation of funds from one expense category to another by submitting the request in writing to the Treasurer at the Society's headquarters. This written request must specify the dollar amount, which categories are impacted, and a justification as to why this change is necessary.

All transfer and/or reallocation requests must be sent to awards@hematology.org. ASH staff will work with the ASH Treasurer to make final determinations.

Changing Mentors

Please contact awards@hematology.org if you need to change mentors. This must be approved by the Chair of the Awards Committee.

Progress Report

AGHA recipients are required to submit to ASH an end of year evaluation form and a current bio-sketch.

Students will need to submit an evaluation form at the end of the first year of their award. The evaluation form is a series of short questions. The form should be accompanied by a letter from a division head or department chair requesting second year funding. It should also provide assurances that the student’s work has progressed and that both appropriate facilities and the mentor will continue to be available.

Failure to submit the progress/evaluation report, including the letter, after the first year, will render the student ineligible for the second year of funding.

Final Reports

A final written report (not to exceed four pages) is expected within 60 days of the end of the award period.

AGHA recipients, along with the financial officers from their institutions, must also submit a financial report detailing how the funds were used over the two-year period. This report must be submitted within 60 days of the end of the award period.

Both final reports must be sent to awards@hematology.org.

Specialties

Hematology

Eligibility Requirements

Applicants must meet the following criteria in order to qualify:

Be planning and committed to conduct the relevant research project in the contiguous United States or Canada.
Be enrolled in a graduate-level course of study at a school or institution in the U.S. or Canada leading to a PhD degree. Applicants must plan to pursue an investigative career in hematology research and be within the first three years of their PhD program. Applicants may submit a formal exception request for the time-based eligibility requirement to awards@hematology.org. Please include the expected graduation date and a justification for the exception in the request.
Propose research focused on a hematologic condition or biological process.
Have clear and documented support of an established ASH member mentor in good standing for the duration of the award term.
Provide documented support from the department chair for dedicated research time during the award period.
Provide a document from an institutional leader who has the authority to ensure that at least 65-75 percent (approximately 2704 – 3120 hours of protected time devoted to research over the two-year time period) of the applicant's full-time professional efforts will be devoted to research during the funded period.
Eligible applicants may not hold other ASH awards during the AGHA award term.
Students pursuing a masters as their terminal degree are not eligible.

Eligible Countries:

Canada

United States

Sponsor Details

Sponsor Institute/Organizations: American Society of Hematology

Address: 2021 L Street NW, Suite 900, Washington, DC 20036 Contact Phone 202-776-0544 Toll Free 866-828-1231 Fax 202-776-0545

Legal & Affiliation Disclaimer

Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.

Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.

Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.

Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.

Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.

Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.

Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.

View Funding Opportunity